KEYES JASON A (Chief Financial Officer) purchased 700.00 shares of BLOSSOMHILL THERAPEUTICS, INC. on the open market
Open‑market purchase worth $11.2K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 8/10/2026ACC: 0001678152-26-000003
Officer· Chief Financial Officer
Since Aug 2026
+57.45K
Net shares
Net buyer
$11.2K
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
57.45K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+700.00
Price / share
$16.00
Trade value
$11.20K
% of position
New position
8/10/2026
0.00→700.00
Total
Net shares
+700.00
Net value
$11.20K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/10/2026 | P · Purchase | +700.00 | $16.00 | $11.20K | New position | 0.00 | 700.00 |
| Total | +700.00 | $11.20K | ||||||
Derivative Transactions1
Employee Stock Option (Right to Buy)
Direct
Converts to
Common Stock
56.75K shares
Shares
+56.75K
Strike price
16
Held after
56.75K
Exercisable
—
8/6/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy) Direct | Common Stock56.75K shares | 8/6/2026 | A · Award | +56.75K | 16 | — | 56.75K |